Medical Equipment

Poc Hba1C Testing Market Forecast Highlighting Key Trends And Expansion Potential

April 15, 2026April 15, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Is The Market Size Of The Poc Hba1C Testing Market Expected To Change From 2026 To 2030?

The poc hba1c testing market size has experienced rapid expansion in recent years. It is forecast to grow from $1.02 billion in 2025 to $1.14 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 11.9%. This past growth can be attributed to several factors, including the rising global prevalence of diabetes, increased clinical reliance on long-term glucose monitoring, the expansion of outpatient diagnostic services, growing awareness of early diabetes diagnosis, and the availability of compact diagnostic instruments.

The poc hba1c testing market size is projected to experience substantial expansion in the coming years. By 2030, this market is anticipated to reach $1.76 billion, growing at a compound annual growth rate (CAGR) of 11.4%. Several factors contribute to this projected growth during the forecast period, including the increased embrace of decentralized diagnostics, a surge in demand for home care testing solutions, the broadening of digital diabetes management initiatives, a heightened emphasis on preventive healthcare, and greater investments in rapid diagnostic technologies. Key trends shaping the forecast period encompass a wider uptake of rapid point-of-care hba1c devices, the expanding utilization of portable and handheld testing systems, an escalating need for home-based diabetes monitoring, the development of integrated poc diagnostic platforms, and an intensified focus on the precision and consistency of tests.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/poc-hba1c-testing-global-market-report

What Key Factors Are Affecting The Poc Hba1C Testing Market Demand?

The expansion of the point-of-care (POC) HbA1C testing market is being propelled by the rising incidence of diabetes. This chronic metabolic condition involves elevated blood glucose, necessitating ongoing surveillance to avert severe health issues like neuropathy, cardiovascular ailments, and renal damage. Globally, the increase in diabetes diagnoses can be attributed to factors including inactive lifestyles, poor dietary choices, escalating rates of obesity, and an aging demographic. The growing number of individuals with diabetes fuels the demand within the POC HbA1C testing market, as it requires swift, accessible, and precise methods for assessing glycemic control across various environments, such as clinics, pharmacies, and home-care settings, thereby facilitating prompt therapeutic interventions. For example, data from the International Diabetes Federation, a Belgium-based health organization, shows that in 2024, around 589 million adults aged 20-79 were living with diabetes. This total is anticipated to reach 853 million by 2050, with more than 4 in 5 adults affected by diabetes residing in low and middle income countries. Consequently, the expanding occurrence of diabetes is a primary catalyst for the development of the POC HbA1C testing market.

How Is The Poc Hba1C Testing Market Organized By Segment Classification?

The poc hba1c testing market covered in this report is segmented –

1) By Type of Product: Instruments, Consumables

2) By Technology: Ion-Exchange HPLC, Enzymatic Assay, Affinity Binding Chromatography, Immunoassay, Other Technologies

3) By End User: Hospitals, Physician Office Or Outpatient Center, Home Care, Other End Users

Subsegments:

1) By Instruments: Handheld HbA1c Testing Devices, Portable HbA1c Analyzers, Desktop HbA1c Testing Systems, Integrated Point Of Care Testing Systems

2) By Consumables: Test Strips, Control Solutions, Reagents, Calibration Solutions, Sample Collection Devices

What Trends Are Influencing Changes In The Poc Hba1C Testing Market?

Leading companies in the point-of-care (POC) HbA1c testing market are progressively integrating built-in internal verification systems to ensure test accuracy, minimize error risks, and bolster trust in near-patient diagnostics. These intrinsic self-check mechanisms continuously monitor ambient conditions, sample integrity, and assay performance during each test to avert erroneous results or sample loss. For example, in July 2024, Siemens Healthineers, a Germany-based company focused on medical technology, launched its next-generation point-of-care Atellica DCA Analyser. The Atellica DCA Analyzer utilizes its exclusive Auto-Checks Technology, which executes a comprehensive suite of internal calibrations and checks throughout the testing procedure, encompassing environmental calibration, airflow and thermal verification, sample volume and integrity examination, optical clarity, and precision assessments. This automated self-monitoring capability guarantees that every HbA1c result, delivered in just 4–5 minutes, meets lab-equivalent quality standards, while simultaneously reducing the demand for continuous operator supervision. By embedding these self-checks, the Atellica DCA aids in minimizing pre-analytical errors, enhancing result confidence, and supporting the scale-up of point of care (POC) testing in settings with limited lab infrastructure.

Who Are The Industry Participants Involved In The Poc Hba1C Testing Market?

Major companies operating in the poc hba1c testing market are F. Hoffmann-La Roche Ltd, Siemens Healthineers AG, Bio-Rad Laboratories Inc, Menarini Group, Danaher Corporation, Tosoh Bioscience Inc, ARKRAY Inc, i-SENS Inc, Abbott Laboratories, Trinity Biotech plc, Aina Blood Monitoring System, Getein Biotech Inc, Sugentech Inc, Alere Inc, EKF Diagnostics, HemoCue, PTS Diagnostics, Osang Healthcare, Ortho Clinical Diagnostics, Ascensia, Platinum Equity (LifeScan), Becton Dickinson and Company, Kainico Ltd, Evia Medical Technologies, Agamatrix Inc, Bionime Corporation

Get The Full Poc Hba1C Testing Market Report:

https://www.thebusinessresearchcompany.com/report/poc-hba1c-testing-global-market-report

Which Region Holds The Highest Market Share In The Poc Hba1C Testing Market?

North America was the largest region in the POC HbA1C testing market in 2025. Africa is expected to be the fastest-growing region in the forecast- period. The regions covered in the poc hba1c testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Poc Hba1C Testing Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/poc-hba1c-testing-global-market-report

Browse Through More Reports Similar to the Global Poc Hba1C Testing Market 2026, By The Business Research Company

Hemoglobin A1C Hba1C Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/hemoglobin-a1c-hba1c-testing-global-market-report

Poc Cholesterol Test Market 2026

https://www.thebusinessresearchcompany.com/report/poc-cholesterol-test-market

Hemoglobin A1C Testing Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/hemoglobin-a1c-testing-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795